Medical Condition News

RSS

MUSC researchers introduce second generation dual-source CT scanner to detect cardiac disease

Researchers from the Medical University of South Carolina (MUSC) are the first in the world to demonstrate the feasibility of a new method of detecting cardiac disease using enhanced computed tomography scanning technology. The findings will be published in the upcoming March / April issue of the Journal of Cardiovascular Computed Tomography.

11 Feb 2010

Neurology researchers explore link between MS and chronic cerebrospinal venous insufficiency

More than 55 percent of multiple sclerosis patients participating in the initial phase of the first randomized clinical study to determine if persons with MS exhibit narrowing of the extracranial veins, causing restriction of normal outflow of blood from the brain, were found to have the abnormality.

11 Feb 2010

Micromet outlines the design of registration study for blinatumomab in ALL

At its annual investor R&D Day today, Micromet, Inc. (Nasdaq: MITI) outlined the design of a registration study for the Company's lead product candidate blinatumomab in acute lymphocytic leukemia (ALL), highlighted clinical data demonstrating the breadth of blinatumomab's activity in B-cell non-Hodgkin's lymphomas and announced plans to expand clinical development of blinatumomab in the U.S.

11 Feb 2010

HDC signs agreement to receive clinical specimens for colon cancer molecular diagnostic test

Health Discovery Corporation announced today that the Company has entered into an exclusive agreement with the Pancreas, Biliary and Liver Surgery Center of New York at Saint Vincent Catholic Medical Centers in New York City to provide clinical specimens to be utilized to complete the final validation of HDC's molecular diagnostic test for colon cancer. This test demonstrated a 93% Sensitivity and a 93% Specificity in a previous validation study.

11 Feb 2010

Principio, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center sign technology licensing agreement

Principio Inc., a privately held emerging company developing novel molecular imaging agents and therapeutic radiopharmaceuticals for the treatment of cancer, today announced that the Company has obtained an exclusive license to several technologies developed at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.

11 Feb 2010

MUHC commences clinical trial of Exsulin for type 1 diabetes

A clinical trial of Exsulin, an innovative new treatment that targets the underlying cause of type 1 diabetes, has begun at the McGill University Health Centre (MUHC). Under the direction of Dr. George Tsoukas of the MUHC and the McGill University Faculty of Medicine, the study will assess the effectiveness of Exsulin.

11 Feb 2010

IDF grants $2 million for new diabetes research projects

Nine new diabetes research projects will be funded for a total of US$2 million over the next three years as part of the International Diabetes Federation's (IDF) translational research grant programme, BRIDGES.

11 Feb 2010

DMC recommends Gamida-Teva JV to continue enrollment in StemEx Phase III trial for leukemia and lymphoma

Elbit Imaging Ltd. announces that its associated company (approximately 28% holding on a fully diluted basis), Gamida Cell Ltd. ("Gamida Cell") through the Gamida-Teva Joint Venture (JV), announced today that the Data Monitoring Committee ("DMC") has independently reviewed preliminary data from the pivotal registration, Phase III clinical trial of StemEx (called ExCell) and has recommended that the JV continue to enroll patients in this study.

11 Feb 2010

QRxPharma announces the initiation of second pivotal Phase 3 registration trial of MoxDuo IR

QRxPharma Limited announced today initiation of its second pivotal Phase 3 registration trial (Study 009) to evaluate analgesic efficacy and safety of MoxDuo™IR, a patented 3:2 ratio fixed dose combination of morphine plus oxycodone.

11 Feb 2010

Migraine sufferers face increase risk of heart attack, says study

People with migraine may be at an increased risk of heart attack and other risk factors for heart disease, according to a study published in the February 10, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

11 Feb 2010

Study may pave for effective treatments for blood clotting disorders

A key protein that causes the blood to clot is produced by blood vessels in the lungs and not just the liver, according to new research published today in the journal PLoS One, led by scientists at Imperial College London.

11 Feb 2010

Bioactive lipid LPA mediates fibrogenesis in bleomycin mouse model of scleroderma

Amira Pharmaceuticals, Inc. announced today that their collaborators, Andrew Tager, M.D. and Flavia V. Castelino, M.D. of Massachusetts General Hospital, Harvard Medical School, will present a preclinical proof-of-concept study which demonstrates that the bioactive lipid lysophosphatidic acid (LPA), through its high affinity LPA1 receptor, is an important mediator of fibrogenesis in the bleomycin mouse model of scleroderma. Data will be presented as part of a poster session for the 1st Systemic Sclerosis World Congress to be held in Florence, Italy, February 11 to 13, 2010.

11 Feb 2010

10th Annual Spring Meeting of ESC on Cardiovascular Nursing and Allied Professionals

Geneva, situated at the heart of Europe, provides a fitting setting for the 10th Annual Spring Meeting of the European Society of Cardiology Council (ESC) on Cardiovascular Nursing and Allied Professionals (CCNAP), 12 - 13 March 2010, with its special theme: "Uniting to Improve Cardiovascular Practice".

11 Feb 2010

CINJ researchers develop new vaccine strategy for pancreatic cancer

More than 42,500 people in the United States were diagnosed with pancreatic cancer last year and nearly 35,200 died from the disease, according to The American Cancer Society.

11 Feb 2010

Study: There are still barriers to veterans getting full course of PTSD treatment

Although the Department of Veteran Affairs is rolling out treatments nationwide as fast as possible to adequately provide for newly diagnosed PTSD patients, there are still significant barriers to veterans getting a full course of PTSD treatment. The study is published in the latest issue of the Journal of Traumatic Stress.

11 Feb 2010

Celebrity promotes fundraising event fro cancer research

KIMBERLY WYATT from the "Pussycat Dolls" has shone brightly to promote Cancer Research UK's latest fundraising event by posing in a bespoke, illuminated dress designed especially for her

11 Feb 2010

Feeding tube use more likely at big, for-profit hospitals

Larger, for-profit hospitals may be using too many feeding tubes on patients with advanced dementia without improving the quality of their care, a study finds, according to HealthDay News/Business Week. "Our results suggest that decisions about feeding tubes are more about which hospital you go to than a decision-making process that really elicits and supports patient choice," said the physician who led the study, which appears in today's Journal of the American Medical Association.

11 Feb 2010

Operation Eyesight urges Canadians to make a difference on Valentine's Day

On Valentine's Day it is traditional to send cards, flowers or a special gift to the people we love. But this year, are you wondering if it's time to try something new? Consider making a tribute gift through Operation Eyesight - it's a powerful way to say "I care" while at the same time helping people in the developing world see a future free of blindness.

10 Feb 2010

$TZD drug may increase fracture risk in older women$

TZD drug may increase fracture risk in older women

A Henry Ford Hospital study finds women with type 2 diabetes who take a commonly prescribed class of medications to treat insulin resistance may be at a higher risk for developing bone fractures.

10 Feb 2010

Women who take AdvaCAL calcium supplements have high bone density

With Osteoporosis an increasing concern among women of all ages, a recent report in the medical journal Osteoporosis International found that women taking the AAACa (AdvaCAL®) calcium supplements had the highest bone density increase among 32 different calcium studies conducted between 1977 and 2008.

10 Feb 2010

Medical Condition News

MUSC researchers introduce second generation dual-source CT scanner to detect cardiac disease

Neurology researchers explore link between MS and chronic cerebrospinal venous insufficiency

Micromet outlines the design of registration study for blinatumomab in ALL

HDC signs agreement to receive clinical specimens for colon cancer molecular diagnostic test

Principio, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center sign technology licensing agreement

MUHC commences clinical trial of Exsulin for type 1 diabetes

IDF grants $2 million for new diabetes research projects

DMC recommends Gamida-Teva JV to continue enrollment in StemEx Phase III trial for leukemia and lymphoma

QRxPharma announces the initiation of second pivotal Phase 3 registration trial of MoxDuo IR

Migraine sufferers face increase risk of heart attack, says study

Study may pave for effective treatments for blood clotting disorders

Bioactive lipid LPA mediates fibrogenesis in bleomycin mouse model of scleroderma

10th Annual Spring Meeting of ESC on Cardiovascular Nursing and Allied Professionals

CINJ researchers develop new vaccine strategy for pancreatic cancer

Study: There are still barriers to veterans getting full course of PTSD treatment

Celebrity promotes fundraising event fro cancer research

Feeding tube use more likely at big, for-profit hospitals

Operation Eyesight urges Canadians to make a difference on Valentine's Day

TZD drug may increase fracture risk in older women

Women who take AdvaCAL calcium supplements have high bone density

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News